Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Active:	Yes
Cancer Type:	Unknown Primary	NCT ID:	NCT04920474
Trial Phases:		Protocol IDs:	NMDP IRB-1991-0002 (primary) NCI-2020-01397 IRB-1991-0002
Eligibility:	0 Years and older, Male and Female	Study Type:	Other
Study Sponsor:	Center for International Blood and Marrow Transplant Research
NCI Full Details:	http://clinicaltrials.gov/show/NCT04920474

Summary

The primary purpose of the Research Sample Repository is to make blood samples available
for research studies related to histocompatibility and hematopoietic cell transplantation
(HCT) or other cellular therapy.

Representatives of participating centers and investigators or research groups may request
access to research samples contained in the Research Sample Repository for the purpose of
conducting research including:

- investigating molecular explanations for histocompatibility or clinical outcomes
through analysis of genomic, epigenetic, or other biomolecular data

- evaluating the factors that affect transplant or cellular therapy outcome

- studying the distribution of HLA tissue types in different populations

- studying the success of transplantation, cellular therapies or supportive care in
the management of marrow toxic injuries

- performing de-linked (anonymous) research

Objectives

Research samples will be accepted from the following four categories:

- Hematopoietic Cell or other Cellular Therapy Donors

- Cord Blood Units

- Hematopoietic Cell Transplantation or other Cellular Therapy Recipients

- Patients with Marrow Toxic Injury

Treatment Sites in Georgia

Georgia Cancer Center at Augusta University
1411 Laney Walker Boulevard
Augusta, GA 30912
www.augusta.edu/cancer/

**Clinical trials are research studies that involve people. These studies test new ways to prevent, detect, diagnose, or treat diseases. People who take part in cancer clinical trials have an opportunity to contribute to scientists’ knowledge about cancer and to help in the development of improved cancer treatments. They also receive state-of-the-art care from cancer experts... Click here to learn more about clinical trials.